cRGD-Functionalized Nanohybrid Conjugates Codelivering Temozolomide and Rapamycin for Treating Glioblastoma Multiforme: In Vitro and In Vivo Evaluation
Year: 2025
Type: article
Source: Molecular Pharmaceutics
Institution: Birla Institute of Technology and Science, Pilani
Language: English
Subfield: Biomaterials
Field: Materials Science
Domain: Physical Sciences
Open Access status: closed
Awards: G2100812780, G3112065730
OpenAlex ID: W4415469596
